| Drug Name: | Regadenoson (313348-27-5) |
|---|---|
| PubChem ID: | 219024 |
| SMILES: | CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O |
| InchiKey: | LZPZPHGJDAGEJZ-AKAIJSEGSA-N |
| Therapeutic Category: | Adenosine A2 Receptor Antagonists, Neurotransmitter Agents, Purinergic Agents, Purinergic Antagonists, Purinergic P1 Receptor Antagonists |
| Molecular Weight (dalton) | : | 390.36 |
| LogP | : | -2.4347 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 12 |
| Hydrogen Bond Donor Count | : | 5 |
| Total Polar Surface Area | : | 186.46 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category